CHRISTOPHER MASSEY: Open Payments
NPI 1417443938 · SAN MARCOS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,628 in 63 payments from 11 companies in 2025. Trend: 2023 $6,196 · 2024 $6,019 · 2025 $2,628
Food & beverage: $2,628
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $712 |
| Globus Medical, Inc. | 13 | $639 |
| Medtronic, Inc. | 17 | $565 |
| Averitas Pharma Inc. | 4 | $225 |
| Nalu Medical, Inc. | 4 | $214 |
| SI-BONE, INC. | 11 | $163 |
| SPR Therapeutics, Inc | 1 | $41 |
| Boston Scientific Corporation | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
Products named: PROCLAIM, Senza, INTELLIS ADAPTIVESTIM, QUTENZA, Nalu Neurostimulation System, PRIMEADVANCED SURESCAN, Vyrsa V1, OCTRODE.
Industry payments across TX — which companies pay providers there.
